Hansa Biopharma's ConfIdeS Phase 3 trial abstract selected for ATC 2026
Dicot Pharma submits FDA application for LIB-01 phase 2b study
European Commission approves Pharming's Joenja for APDS treatment in the EU
Caliway Biopharmaceuticals receives US FDA IND clearance for second global Phase 3 study of CBL-514
AbbVie's MAVIRET receives positive opinion from European regulator
Enhertu recommended for EU approval in previously treated HER2 positive metastatic solid tumours
OSE Immunotherapeutics reports positive Phase 2 ovarian cancer trial results
INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100
Sobi reports positive topline results from Phase 3 study of pozdeutinurad in gout
Bayer's KERENDIA receives FDA priority review for type 1 diabetes and kidney disease treatment
Circio files new patent application for circVec gene therapy platform
Hyundai Bioscience says XAFTY available for Ebola and Hantavirus treatment
4basebio secures clinical supply agreement for Phase II immunotherapy trial